Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-396935

Director acquired 75 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Behbahani Ali · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-08-06 Other acquisition : show line 1 in the form +60 316 D
2025-08-06 Other acquisition : show line 2 in the form +15 29 I
Loading xslF345X06/ownership.xml…